Last edition
News about "WuXi Biologics Unveils WuXia293Stable Platform to "
WuXi Biologics Unveils WuXia293Stable Platform to Advance Manufacturing of Complex Biologics
Featuring high titers, robust stability and superior quality, the platform enhances both the developability and manufacturability of complex biologics, providing an efficient chemistry, manufacturing and controls (CMC) solution for sophisticated structures and functions.
WuXi Biologics Unveils WuXia293Stable Platform To | 12/08/2025 | By Darshana | 169
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members